Tradestie Institutional Equity Comparison Engine

NVS vs AMGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AMGN Overall Edge

AMGN Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Amgen Inc (AMGN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NVS trades at 16.2x Forward P/E with 34.0% operating margin (+4.7% YoY revenue) versus AMGN at 18.6x Forward P/E and 34.1% operating margin (+8.5% YoY). In options structure, NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against AMGN sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AMGN
NVS 16.2x vs AMGN 18.6x Fwd P/E
Growth & Margin Winner AMGN
Op Margin 34.0% vs 34.1% ยท YoY +4.7% vs +8.5%
Momentum & Technical Winner AMGN
1Y +22.5% vs +38.9% ยท 52W Pos 81% vs 90%
Options & Structure Winner AMGN
UNCLASSIFIED (6th %ile IV) vs CONSOLIDATION (10th %ile IV)
NVS NYSE
Novartis AG
Pharmaceutical Preparations
$161.59
+0.68% 1D
Market Cap $302.9B
1M Return +7.28%
1Y Return +22.5%
Forward P/E 16.2x
Unified AI Score
41.5 / 100 SELL
Tech 29.0 Fund 38.0 Flow 50.0 Mom 21.1
AMGN NASDAQ
Amgen Inc
Biological Products, (No Disgnostic Substances)
$466.83
+0.25% 1D
Market Cap $252.6B
1M Return +7.94%
1Y Return +38.94%
Forward P/E 18.6x
Unified AI Score
42.2 / 100 HOLD
Tech 24.0 Fund 50.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NVS +22.5% AMGN +38.94% Spread: +16.44 pp (AMGN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NVS TTM Op. Margin: 34.0% AMGN TTM Op. Margin: 34.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVS vs AMGN. Trailing 12-month operating profitability (NVS 34.0% vs AMGN 34.1%) and valuation multiples (NVS 16.2x vs AMGN 18.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NVS (2) vs AMGN (7)
Institutional Metric NVS AMGN Criterion Row Winner
Market Capitalization Scale $302.9B $252.6B Larger Scale NVS
Trailing P/E Ratio Valuation 30.6x 27.1x Lower Multiple AMGN
Forward P/E Ratio Valuation 16.2x 18.6x Lower Multiple NVS
Revenue Growth (YoY) Growth +4.7% +8.5% Higher Growth AMGN
Operating Margin (TTM) Profitability 34.0% 34.1% Higher Margin Tie
Net Profit Margin Profitability 17.5% 24.1% Higher Margin AMGN
Return on Equity (ROE) Capital Efficiency 24.3% 78.3% Higher ROE AMGN
52-Week Range Position Momentum 81% ($123โ€“$170) 90% ($312โ€“$484) Stronger Trend AMGN
Beta / 30D Volatility Risk Regime 0.31ฮฒ ยท 27% Vol 0.47ฮฒ ยท 26% Vol Lower Realized Risk AMGN
Unified Institutional Score Composite Signal 41.5 / 100 (SELL) 42.2 / 100 (HOLD) Higher Composite AMGN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NVS vs AMGN Buy Guide
NVS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live NVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AMGN CONSOLIDATION
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live AMGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NVS nor AMGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.